Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Arcinova Q3 Newsletter 2016

We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our offerings to our customers. 

Click to view newsletter

 

 

 

 

 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH